QBC Diagnostics Awarded GSA Contract

PORT MATILDA, Penn., April 23, 2012 /PRNewswire/ -- QBC Diagnostics, a global manufacturer of hematology and infectious disease diagnostics equipment, announced today that the company has been awarded a U.S. General Services Administration (GSA) Schedule 66 Contract for Scientific Equipment and Services.

GSA's Scientific Equipment and Services Schedule 66 Contract provides federal agencies with scientific instruments for a wide variety of uses such as public safety, medical research, and laboratory diagnostics. Under contract number GS-07F-0306Y, QBC Diagnostics has been approved to sell to government agencies for all of their major product lines, including the QBC STAR Hematology Analyzer and the QBC ParaLens Advance Fluorescence Microscopy Attachment.

"We are thrilled to be able to offer an efficient and reliable means of supplying our government partners with our entire line of products," said Craig Stout, QBC Diagnostics' General Manager and Vice President. "QBC is highly committed to providing our customers with innovative tools such as our unique line of dry hematology analyzers and fluorescence microscopy products, and this contract further strengthens our past relationships with government agencies."

Currently, QBC has a number of its QBC STAR Hematology analyzers installed on over 250 U.S. Navy Vessels, including both surface and submarine forces. Working closely with the U.S. Department of State, QBC diagnostics also provides hematology solutions to more than 50 United States Embassies worldwide. The QBC ParaLens Advance can be found in a number of National Tuberculosis Programs around the globe, and is considered a leader in the field of fluorescence microscopy.

QBC Diagnostics is presently working on finalizing their contract price list with GSAAdvantage!®, which should be made available shortly. In the interim, QBC has asked that all inquiries pertaining to GSA pricing should be directed to their sales team for further information.

About QBC Diagnostics

QBC Diagnostics is a privately held company headquartered in Port Matilda, Pennsylvania.  The company manufactures a line of complete blood count analyzers and fluorescence microscopy products.  Additional information can be found by visiting the company website (www.qbcdiagnostics.com) or by calling +1-814-692-7661.  Follow QBC on Twitter or Facebook for further updates.

SOURCE QBC Diagnostics